Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming.

Armstrong LC, Westlake G, Snow JP, Cawthon B, Armour E, Bowman AB, Ess KC
Hum Mol Genet. 2017 26 (23): 4629-4641

PMID: 28973543 · PMCID: PMC5886307 · DOI:10.1093/hmg/ddx345

Tuberous sclerosis complex (TSC) is a pediatric disorder of dysregulated growth and differentiation caused by loss of function mutations in either the TSC1 or TSC2 genes, which regulate mTOR kinase activity. To study aberrations of early development in TSC, we generated induced pluripotent stem cells using dermal fibroblasts obtained from patients with TSC. During validation, we found that stem cells generated from TSC patients had a very high rate of integration of the reprogramming plasmid containing a shRNA against TP53. We also found that loss of one allele of TSC2 in human fibroblasts is sufficient to increase p53 levels and impair stem cell reprogramming. Increased p53 was also observed in TSC2 heterozygous and homozygous mutant human stem cells, suggesting that the interactions between TSC2 and p53 are consistent across cell types and gene dosage. These results support important contributions of TSC2 heterozygous and homozygous mutant cells to the pathogenesis of TSC and the important role of p53 during reprogramming.

© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

MeSH Terms (24)

Adolescent Adult Alleles Cellular Reprogramming Child Child, Preschool Female Fibroblasts Genes, p53 Heterozygote Humans Induced Pluripotent Stem Cells Infant Loss of Heterozygosity Male Mutation RNA, Small Interfering Signal Transduction TOR Serine-Threonine Kinases Tuberous Sclerosis Tuberous Sclerosis Complex 1 Protein Tuberous Sclerosis Complex 2 Protein Tumor Suppressor Protein p53 Tumor Suppressor Proteins

Connections (1)

This publication is referenced by other Labnodes entities: